XTX Topco’s ADMA Biologics ADMA Stock Holding History

XTX Topco’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.98M	Buy	+552,793	New	+$8.72M	0.09%	284
2025 Q4	–	Sell	-86,503	Closed	-$1.27M	–	3266
2025 Q3	$1.27M	Buy	+86,503	New	+$1.48M	0.07%	432
2025 Q2	–	Sell	-12,073	Closed	-$240K	–	2287
2025 Q1	$240K	Sell	12,073 -11,034	-48%	-$191K	0.01%	1575
2024 Q4	$396K	Buy	+23,107	New	+$435K	0.03%	968
2024 Q2	–	Sell	-106,841	Closed	-$705K	–	1803
2024 Q1	$705K	Sell	106,841 -62,232	-37%	-$340K	0.1%	292
2023 Q4	$764K	Buy	169,073 +120,052	+245%	+$444K	0.17%	79
2023 Q3	$175K	Buy	49,021 +37,423	+323%	+$144K	0.03%	1058
2023 Q2	$42.8K	Sell	11,598 -94,398	-89%	-$350K	0.01%	1258
2023 Q1	$351K	Buy	105,996 +95,372	+898%	+$330K	0.07%	531
2022 Q4	$41.2K	Sell	10,624 -10,704	-50%	-$33K	0.01%	1052
2022 Q3	$52K	Buy	+21,328	New	+$51.2K	0.01%	1019
2021 Q4	–	Sell	-17,709	Closed	-$20K	–	648
2021 Q3	$20K	Sell	17,709 -7,172	-29%	-$10K	0.01%	640
2021 Q2	$40K	Buy	+24,881	New	+$43.8K	0.01%	740

Other funds holding ADMA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

XTX Topco's ADMA Position: Q1 2026 in Review

XTX Topco opened a new position in ADMA Biologics (ADMA) in Q1 2026: 552,793 shares worth $4.98M. The stake represents 0.09% of the portfolio and ranks #284 among its holdings. This is a return to the name: XTX Topco previously reported a position in ADMA as recently as Q3 2025.

XTX Topco first reported a position in ADMA in Q2 2021 and has held it in 13 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

XTX Topco held 552,793 shares of ADMA Biologics worth $4.98M as of Q1 2026.
ADMA Biologics was a new XTX Topco position in Q1 2026.
ADMA Biologics made up 0.09% of XTX Topco's portfolio in Q1 2026, its #284 holding.
XTX Topco first reported a position in ADMA Biologics in Q2 2021 and has held it in 13 quarters since.
356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.